US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
CN1074422C
(zh)
*
|
1987-11-18 |
2001-11-07 |
希龙股份有限公司 |
制备含有hcv表位的分离多肽的方法
|
US5683864A
(en)
*
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US5698390A
(en)
*
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
AU650038B2
(en)
*
|
1988-03-11 |
1994-06-09 |
Abbott Laboratories |
CKS method of protein synthesis
|
JP2696116B2
(ja)
*
|
1988-09-30 |
1998-01-14 |
財団法人阪大微生物病研究会 |
非a非b肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするdna
|
US5191064A
(en)
*
|
1988-09-30 |
1993-03-02 |
The Research Foundation For Microbial Diseases (Osaka University) |
Non-a, non-b hepatitis virus antigen peptide
|
JPH02167081A
(ja)
*
|
1988-12-21 |
1990-06-27 |
Tetsuo Nakamura |
非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質
|
UA50829C2
(uk)
*
|
1989-03-17 |
2002-11-15 |
Чірон Корпорейшн |
Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
JP2656996B2
(ja)
*
|
1989-05-18 |
1997-09-24 |
カイロン コーポレイション |
Nanbvの診断用薬
|
JPH0330676A
(ja)
*
|
1989-06-28 |
1991-02-08 |
Sanwa Kagaku Kenkyusho Co Ltd |
非a非b型肝炎ウイルスのdna、そのクローン及びこれらの調製法
|
EP0416725A3
(en)
*
|
1989-07-14 |
1991-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
|
ES2110411T3
(es)
*
|
1989-08-25 |
1998-02-16 |
Chiron Corp |
Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
|
US5372928A
(en)
*
|
1989-09-15 |
1994-12-13 |
Chiron Corporation |
Hepatitis C virus isolates
|
JP3156200B2
(ja)
*
|
1989-09-15 |
2001-04-16 |
国立予防衛生研究所長 |
新規のhcv分離株
|
FR2654113A1
(fr)
*
|
1989-11-09 |
1991-05-10 |
Pasteur Institut |
Procede de diagnostic de virus appartenant a la famille des flaviviridae.
|
US7166287B1
(en)
|
1989-12-18 |
2007-01-23 |
Glaxo Wellcome Inc. |
Viral agent
|
HUT56883A
(en)
*
|
1989-12-18 |
1991-10-28 |
Wellcome Found |
Process for producing virus polypeptides
|
US5308750A
(en)
*
|
1989-12-22 |
1994-05-03 |
Abbott Laboratories |
Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
|
CA2032907C
(en)
*
|
1989-12-22 |
2002-05-14 |
Richard R. Lesniewski |
Hepatitis c assay
|
EP0435229A1
(en)
*
|
1989-12-27 |
1991-07-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
|
EP0441644B1
(en)
*
|
1990-02-09 |
1996-09-11 |
Immuno Japan Inc. |
Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US5106726A
(en)
*
|
1990-02-16 |
1992-04-21 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV
|
US5747239A
(en)
*
|
1990-02-16 |
1998-05-05 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
|
KR940000755B1
(ko)
*
|
1990-02-16 |
1994-01-29 |
유나이티드 바이오메디칼 인코오포레이티드 |
Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5639594A
(en)
*
|
1990-02-16 |
1997-06-17 |
United Biomedical, Inc. |
Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
EP0445801A3
(en)
*
|
1990-03-08 |
1992-07-01 |
Kuraray Co., Ltd. |
Peptide and its use
|
EP0447984A1
(en)
*
|
1990-03-20 |
1991-09-25 |
Abbott Laboratories |
Hyperimmune globulin against hepatitis C virus and method for making same
|
JPH0436185A
(ja)
*
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
WO1991014779A1
(en)
*
|
1990-03-28 |
1991-10-03 |
Mitsui Toatsu Chemicals, Incorporated |
Diagnostic for hepatitis virus
|
US6194140B1
(en)
|
1990-04-04 |
2001-02-27 |
Chiron Corporation |
HCV NS3 protein fragments having helicase activity and improved solubility
|
BR9106309A
(pt)
*
|
1990-04-04 |
1993-04-20 |
Chiron Corp |
Combinacao de antigenos sinteticos de hepatite c viral (hcv),processo de detectar anticorpos para o virus da hepatite c e estojo para realizar teste
|
US5712087A
(en)
*
|
1990-04-04 |
1998-01-27 |
Chiron Corporation |
Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
|
ATE270326T1
(de)
*
|
1990-04-04 |
2004-07-15 |
Chiron Corp |
Protease von hepatitis-c-virus
|
JPH05506230A
(ja)
*
|
1990-04-06 |
1993-09-16 |
ジーンラブス テクノロジイズ インコーポレイテッド |
C型肝炎ウイルスエピトープ
|
CA2044296A1
(en)
*
|
1990-06-12 |
1991-12-13 |
Hiroaki Okamoto |
Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
JP3050395B2
(ja)
*
|
1990-06-12 |
2000-06-12 |
国立感染症研究所長 |
C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
|
US5747339A
(en)
|
1990-06-25 |
1998-05-05 |
Research Foundation For Microbial Diseases Of Osaka |
Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
|
AU652941B2
(en)
*
|
1990-06-25 |
1994-09-15 |
Research Foundation For Microbial Diseases Of Osaka University, The |
Non-A, Non-B hepatitis virus particles
|
EP0464287A1
(en)
*
|
1990-06-25 |
1992-01-08 |
The Research Foundation for Microbial Diseases of Osaka University |
Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
|
DE69106141T2
(de)
*
|
1990-06-30 |
1995-05-24 |
Akzo Nobel Nv |
Non-a non-b sequenzen.
|
EP0468657A3
(en)
*
|
1990-07-09 |
1992-02-05 |
Tonen Corporation |
Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
|
DE69125066T2
(de)
*
|
1990-07-11 |
1997-09-25 |
Shionogi Seiyaku K K Trading U |
cDNS-Sequenz und Detektion des Hepatitis C-Virus
|
WO1992001714A1
(en)
*
|
1990-07-24 |
1992-02-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Non-a non-b hepatitis virus antigen
|
CA2047792C
(en)
*
|
1990-07-26 |
2002-07-02 |
Chang Y. Wang |
Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
|
US6172189B1
(en)
*
|
1990-08-24 |
2001-01-09 |
Abbott Laboratories |
Hepatitis C assay utilizing recombinant antigens
|
CA2049679C
(en)
*
|
1990-08-24 |
2005-06-21 |
Sushil G. Devare |
Hepatitis c assay utilizing recombinant antigens
|
DK1227323T4
(da)
*
|
1990-08-25 |
2011-04-26 |
Bioprocess Pty Ltd |
Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner
|
US7863008B2
(en)
|
1990-08-25 |
2011-01-04 |
Bioprocess Pty Ltd. |
Method for detecting NANBV associated seroconversion
|
KR930702506A
(ko)
*
|
1990-10-12 |
1993-09-09 |
찰스 엠. 브록 |
C형 간염 바이러스 항체
|
JP3549201B2
(ja)
*
|
1990-10-24 |
2004-08-04 |
中外製薬株式会社 |
非a非b型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
|
DE4034982C2
(de)
*
|
1990-11-03 |
1999-12-23 |
Dade Behring Marburg Gmbh |
Synthetische Polypeptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE4112743C2
(de)
*
|
1991-04-19 |
2000-01-13 |
Dade Behring Marburg Gmbh |
Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE59109221D1
(de)
*
|
1990-11-03 |
2001-11-15 |
Dade Behring Marburg Gmbh |
HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
|
DE4120281C2
(de)
*
|
1991-06-19 |
1999-11-25 |
Dade Behring Marburg Gmbh |
Immunchemisches Verfahren zum gleichzeitigen Nachweis von mehreren verschiedenen Antikörperspezifitäten, Peptidmischungen und Test dazu
|
DE4121431A1
(de)
*
|
1991-06-28 |
1993-01-07 |
Behringwerke Ag |
Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
ATE178096T1
(de)
*
|
1990-11-07 |
1999-04-15 |
Abbott Lab |
Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen
|
RO115446B1
(ro)
*
|
1990-11-08 |
2000-02-28 |
Chiron Corp |
Procedeu de obtinere a asialoglicoproteinelor purificate provenind de la virusul hepatitei c
|
CA2055149A1
(en)
*
|
1990-11-08 |
1992-05-09 |
Hiroaki Okamoto |
Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
|
US6274148B1
(en)
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
KR920703640A
(ko)
*
|
1990-11-29 |
1992-12-18 |
테루카츄 아리마 |
비a비b형 간염 바이러스 항원 단백질
|
DK0488812T3
(da)
*
|
1990-11-30 |
1999-12-13 |
Japan Immuno Inc |
Non-A, non-B hepatitis-relaterede nucleinsyrer, antigener og antistoffer samt reagenser til deres påvisning
|
US6007982A
(en)
*
|
1990-12-14 |
1999-12-28 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
DK0489968T3
(da)
*
|
1990-12-14 |
1997-03-24 |
Innogenetics Nv |
Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
|
US5910404A
(en)
|
1990-12-14 |
1999-06-08 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
KR930703613A
(ko)
*
|
1991-01-25 |
1993-11-30 |
챨스 엠. 브록 |
시료 희석물중 과산화물 디스뮤타제의 용도
|
JP3483555B2
(ja)
*
|
1991-01-31 |
2004-01-06 |
アボット・ラボラトリーズ |
推定hcvエンベロープ領域に対するモノクローナル抗体およびその使用方法
|
AU640569B2
(en)
*
|
1991-03-26 |
1993-08-26 |
Dade International Inc. |
Assay for non-a non-b hepatitis
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
EP0516270A3
(en)
*
|
1991-04-10 |
1993-06-23 |
Immuno Japan Inc. |
Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
|
WO1992018532A1
(en)
*
|
1991-04-17 |
1992-10-29 |
Eisai Co., Ltd. |
Rna, dna and virus antigen protein of non-a non-b hepatitis virus
|
EP0510952A1
(en)
*
|
1991-04-26 |
1992-10-28 |
Immuno Japan Inc. |
Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
ES2207633T3
(es)
*
|
1991-05-08 |
2004-06-01 |
Chiron Corporation |
Secuencias genomicas del vhc para diagnostico y tratamiento.
|
ES2040615B1
(es)
*
|
1991-05-27 |
1994-05-16 |
Nebrda Fernando Javi Bartolome |
Procedimiento para el aislamiento y clonaje de cdnas derivados del virus c de la hepatitis.
|
FR2677372B1
(fr)
*
|
1991-06-06 |
1994-11-10 |
Pasteur Institut |
Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
|
GB2272443B
(en)
|
1991-06-10 |
1995-10-25 |
Lucky Ltd |
Nucleotide and amino acid sequences of Korean hepatitis C virus
|
CA2070952A1
(en)
*
|
1991-06-11 |
1992-12-12 |
Makoto Seki |
Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
|
DE69232871T2
(de)
*
|
1991-06-24 |
2003-05-08 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Polypeptide des hepatitis c-virus (hiv)
|
DE4209215A1
(de)
|
1991-07-04 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Hcv peptidantigene und verfahren zur bestimmung von hcv
|
JPH06510191A
(ja)
*
|
1991-08-21 |
1994-11-17 |
アボツト・ラボラトリーズ |
Ns1に対する組換え抗原を利用したc型肝炎アッセイ
|
CA2115925A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Suresh M. Desai |
Hepatitis c assay utilizing recombinant antigens from ns5 region
|
ES2126598T3
(es)
*
|
1991-08-21 |
1999-04-01 |
Abbott Lab |
Anticuerpos monoclonales que se fijan sobre las proteinas ns5 supuestas del virus de la hepatitis c, y procedimientos de utilizacion de estos anticuerpos.
|
EP0787807B1
(en)
*
|
1991-08-27 |
2003-05-28 |
F. Hoffmann-La Roche Ag |
Primers and probes for hepatitis C detection
|
HU227510B1
(en)
|
1991-09-13 |
2011-07-28 |
Novartis Vaccines & Diagnostic |
Immunoreactive hepatitis c virus polypeptide compositions
|
ZA927837B
(en)
*
|
1991-10-15 |
1994-03-11 |
Akzo Nv |
Monoclonal antibodiesto hepatitis C virus
|
JPH05130874A
(ja)
*
|
1991-11-07 |
1993-05-28 |
Sanwa Kagaku Kenkyusho Co Ltd |
ヒトC型肝炎ウイルスのcDNA、そのクローン及びこれらの利用法
|
AU3063992A
(en)
*
|
1991-11-07 |
1993-06-07 |
Dade International Inc. |
Epitope mapping ot the c33c region of hcv
|
CA2123875C
(en)
*
|
1991-11-21 |
2005-05-24 |
Peter Simmons |
Hepatitis-c virus testing
|
JP3439209B2
(ja)
*
|
1992-01-31 |
2003-08-25 |
アボツト・ラボラトリーズ |
Hcv蛋白のための哺乳動物発現システム
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
US6620414B2
(en)
|
1992-03-27 |
2003-09-16 |
Smithkline Beecham Biologicals (S.A.) |
Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
|
MY111880A
(en)
*
|
1992-03-27 |
2001-02-28 |
Smithkline Beecham Biologicals S A |
Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
|
US5866139A
(en)
*
|
1992-06-04 |
1999-02-02 |
Institut Pasteur |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
|
US5980899A
(en)
*
|
1992-06-10 |
1999-11-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
|
UA39944C2
(uk)
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
US5859230A
(en)
*
|
1992-07-30 |
1999-01-12 |
Genelabs Technologies, Inc. |
Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
|
DE4240980A1
(de)
*
|
1992-08-07 |
1994-02-10 |
Boehringer Mannheim Gmbh |
HCV Peptidantigene und Verfahren zur Bestimmung von HCV
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
NZ255578A
(en)
|
1992-09-10 |
1996-11-26 |
Chemo Sero Therapeut Res Inst |
Antisense oligonucleotides complementary and hybridizable to a portion of hepatitis c virus and their use in treating hepatitis c virus associated diseases
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
US6995146B2
(en)
|
1992-09-10 |
2006-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
US5922857A
(en)
*
|
1992-09-28 |
1999-07-13 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
CN1059928C
(zh)
*
|
1992-09-29 |
2000-12-27 |
天津普生生物科技有限公司 |
利用大肠杆菌制备可用来检验c型肝炎之抗原蛋白的方法
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
EP0593291A3
(en)
*
|
1992-10-16 |
1995-03-15 |
Evernew Biotech Inc |
Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
|
JPH06153959A
(ja)
*
|
1992-10-16 |
1994-06-03 |
Evernew Biotec Inc |
C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
KR950704354A
(ko)
*
|
1992-12-07 |
1995-11-20 |
에프.쥐.엠, 헤르만스 페.카.브론스 |
씨(c)형 간염 바이러스(hcv)씨(c)33 영역 유래의 펩티드, 이에 대한 항체 및 씨(c)형 간염 바이러스를 검출하는 방법(peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv)
|
AU6653394A
(en)
*
|
1992-12-07 |
1994-07-04 |
Akzo Nobel N.V. |
Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
|
WO1994024565A1
(en)
*
|
1993-04-22 |
1994-10-27 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
EP0984067B1
(en)
*
|
1993-04-27 |
2012-04-04 |
Innogenetics N.V. |
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
|
ES2231773T3
(es)
|
1993-05-05 |
2005-05-16 |
Common Services Agency |
Virus de la hepatitis c de tipo 4, 5 y 6.
|
SK282543B6
(sk)
*
|
1993-05-10 |
2002-10-08 |
Chiron Corporation |
Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe
|
CA2162557C
(en)
|
1993-05-12 |
2004-09-28 |
Amy J. Weiner |
Conserved motif of hepatitis c virus e2/ns1 region
|
EP0729973A4
(en)
*
|
1993-10-29 |
1998-12-30 |
Srl Inc |
AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE
|
US5610009A
(en)
*
|
1994-01-28 |
1997-03-11 |
Abbott Laboratories |
Mammalian expression systems for hepatitis C virus envelope genes
|
US6051374A
(en)
*
|
1994-02-14 |
2000-04-18 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5981172A
(en)
*
|
1994-02-14 |
1999-11-09 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
|
US6156495A
(en)
*
|
1994-02-14 |
2000-12-05 |
Abbott Laboratories |
Hepatitis GB virus recombinant proteins and uses thereof
|
US6720166B2
(en)
|
1994-02-14 |
2004-04-13 |
Abbott Laboratories |
Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
|
US6451578B1
(en)
|
1994-02-14 |
2002-09-17 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5843450A
(en)
*
|
1994-02-14 |
1998-12-01 |
Abbott Laboratories |
Hepatitis GB Virus synthetic peptides and uses thereof
|
US6558898B1
(en)
|
1994-02-14 |
2003-05-06 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5874563A
(en)
*
|
1994-05-20 |
1999-02-23 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
US5824507A
(en)
*
|
1994-05-20 |
1998-10-20 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
JP3217600B2
(ja)
|
1994-07-12 |
2001-10-09 |
株式会社先端生命科学研究所 |
非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
|
AU3241095A
(en)
*
|
1994-07-29 |
1996-03-04 |
Chiron Corporation |
Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
|
JP3793571B2
(ja)
|
1994-07-29 |
2006-07-05 |
カイロン コーポレイション |
新規c型肝炎e1およびe2短縮型ポリペプチドならびにこれらを得る方法
|
DE4428705A1
(de)
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US5807670A
(en)
*
|
1995-08-14 |
1998-09-15 |
Abbott Laboratories |
Detection of hepatitis GB virus genotypes
|
US5709997A
(en)
*
|
1995-08-14 |
1998-01-20 |
Abbott Laboratories |
Nucleic acid detection of hepatitis GB virus
|
US5955318A
(en)
*
|
1995-08-14 |
1999-09-21 |
Abbott Laboratories |
Reagents and methods useful for controlling the translation of hepatitis GBV proteins
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
GB9517926D0
(en)
|
1995-09-01 |
1995-11-01 |
Biocine Spa |
Binding protein
|
US5851758A
(en)
*
|
1995-10-25 |
1998-12-22 |
Childrens Research Institute |
Cytopathic replication of hepatitis C virus in a new cell line
|
US5837442A
(en)
|
1995-11-29 |
1998-11-17 |
Roche Molecular Systems, Inc. |
Oligonucleotide primers for amplifying HCV nucleic acid
|
US5851759A
(en)
*
|
1996-04-19 |
1998-12-22 |
Chiron Corporation |
Heteroduplex tracking assay (HTA) for genotyping HCV
|
JP3715027B2
(ja)
|
1996-05-07 |
2005-11-09 |
シスメックス株式会社 |
C型肝炎ウイルス感染症診断薬
|
CU22642A1
(es)
*
|
1996-12-12 |
2000-12-22 |
Ct Ingenieria Genetica Biotech |
Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
WO1998050556A2
(en)
|
1997-05-06 |
1998-11-12 |
Chiron Corporation |
Intracellular production of hepatitis c e1 and e2 truncated polypeptides
|
US6010848A
(en)
*
|
1997-07-02 |
2000-01-04 |
Smithkline Beecham Corporation |
Screening methods using an atpase protein from hepatitis C virus
|
US6153392A
(en)
*
|
1997-07-30 |
2000-11-28 |
Bionova Corporation |
Devices and methods comprising an HBcAg from hepatitis B virus
|
DE69841322D1
(de)
|
1997-10-06 |
2010-01-07 |
Novartis Vaccines & Diagnostic |
Hepatitis c rezeptorprotein cd81
|
EP2278006A3
(en)
|
1997-11-06 |
2011-03-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
US6228576B1
(en)
|
1997-12-11 |
2001-05-08 |
Smithkline Beecham Corporation |
Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
|
SG152917A1
(en)
|
1998-01-14 |
2009-06-29 |
Chiron Srl |
Neisseria meningitidis antigens
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP1944371B1
(en)
|
1998-05-01 |
2015-03-04 |
Novartis AG |
Neisseria meningitidis antigens and compositions
|
ES2350306T3
(es)
|
1999-02-26 |
2011-01-20 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de bioadhesivos y adyuvantes para la administración de antígenos por vía mucosa.
|
CA2689696C
(en)
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
WO2001021189A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
ES2564463T3
(es)
|
1999-10-29 |
2016-03-22 |
Glaxosmithkline Biologicals S.A. |
Péptidos antigénicos de Neisseriales
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
EP1233782B1
(en)
*
|
1999-12-01 |
2008-11-05 |
Novartis Vaccines and Diagnostics, Inc. |
Eliciting hcv-specific antibodies
|
WO2001052885A1
(en)
|
2000-01-17 |
2001-07-26 |
Chiron Spa |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
AU2001253124A1
(en)
|
2000-04-05 |
2001-10-23 |
Schering Corporation |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
|
HUP0302957A2
(hu)
|
2000-04-19 |
2003-12-29 |
Schering Corporation |
Hepatitis C vírus alkil- és aril-alanin P2 csoportokat tartalmazó makrociklusos NS-3 szerin proteáz inhibitorai
|
EP1829891B1
(en)
*
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Immunoassays for Anti-HCV Antibodies
|
ES2277932T5
(es)
|
2000-06-15 |
2010-06-28 |
Novartis Vaccines And Diagnostics, Inc. |
Ensayo de combinacion de antigeno/anticuerpo del vhc.
|
DK1385870T3
(da)
|
2000-07-21 |
2010-07-05 |
Schering Corp |
Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
US7169760B2
(en)
|
2000-07-21 |
2007-01-30 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
AU2001290178A1
(en)
*
|
2000-08-17 |
2002-02-25 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
US6858590B2
(en)
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
EP2189473A3
(en)
|
2000-10-27 |
2010-08-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic and proteins from streptococcus groups A & B
|
CA2430458A1
(en)
|
2000-12-12 |
2002-06-20 |
Schering Corporation |
Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
JP4608210B2
(ja)
|
2001-05-31 |
2011-01-12 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
キメラアルファウイルスレプリコン粒子
|
US7196183B2
(en)
|
2001-08-31 |
2007-03-27 |
Innogenetics N.V. |
Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
NZ533861A
(en)
|
2002-01-23 |
2006-03-31 |
Schering Corp |
Proline compounds as NS3-serine protease inhibitors for use in treatment of hepatitis C virus infection
|
CA2476626A1
(en)
|
2002-02-20 |
2003-08-28 |
Chiron Corporation |
Microparticles with adsorbed polypeptide-containing molecules
|
DK1947104T3
(da)
|
2002-03-11 |
2012-08-06 |
Lab 21 Ltd |
Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
EP1521767B1
(en)
|
2002-05-24 |
2009-12-16 |
Restoragen Inc. |
Methods and constructs for high yield expression of clostripain
|
PL209710B1
(pl)
|
2002-09-09 |
2011-10-31 |
Chiron Corp |
Sposób wykrywania infekcji wirusem zapalenia wątroby typu C (HCV)
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
EP2977470B1
(en)
|
2002-10-16 |
2018-01-03 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
ATE552843T1
(de)
|
2003-02-06 |
2012-04-15 |
Aduro Biotech |
Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
CA2515298C
(en)
|
2003-02-06 |
2014-04-08 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
CA2536570A1
(en)
|
2003-08-26 |
2005-03-10 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
US8124747B2
(en)
|
2003-08-29 |
2012-02-28 |
Innogenetics |
HCV clade and prototype sequences thereof
|
WO2005028503A1
(ja)
|
2003-09-22 |
2005-03-31 |
Green Peptide Co., Ltd. |
C型肝炎ウイルス由来ペプチド
|
CA2540031A1
(en)
|
2003-09-26 |
2005-04-07 |
Schering Corporation |
Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
|
KR100853579B1
(ko)
*
|
2003-10-14 |
2008-08-21 |
인터뮨, 인크. |
Hcv 복제 억제제로서 거대고리 카르복실산 및아실술폰아미드
|
JP2007532479A
(ja)
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
C型肝炎ウイルスns3プロテアーゼの脱ペプチド化インヒビター
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
JP2007525510A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼのインヒビターとしての化合物
|
JP2007525512A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼのインヒビターとしての3,4−(シクロペンチル)−縮合プロリン化合物
|
ES2327544T3
(es)
|
2004-02-27 |
2009-10-30 |
Schering Corporation |
Compuestos novedosos como inhibidores de serina proteasa ns3 de virus de hepetitis c.
|
WO2005085275A1
(en)
|
2004-02-27 |
2005-09-15 |
Schering Corporation |
Inhibitors of hepatitis c virus ns3 protease
|
ES2328596T3
(es)
|
2004-05-20 |
2009-11-16 |
Schering Corporation |
Prolinas sustituidas como inhibidores de la serina proteasa del virus ns3 de la hepatitis c.
|
CA2575548A1
(en)
|
2004-07-29 |
2006-07-27 |
John L. Telford |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
ATE542140T1
(de)
|
2004-08-27 |
2012-02-15 |
Novartis Vaccines & Diagnostic |
Nichtstrukturelle hcv-proteinmutanten und verwendungsmöglichkeiten dafür
|
CA2577812A1
(en)
|
2004-08-27 |
2006-03-09 |
Schering Corporation |
Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease
|
SG158148A1
(en)
|
2004-12-22 |
2010-01-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
CN103285392A
(zh)
|
2005-04-26 |
2013-09-11 |
卫材R&D管理株式会社 |
用于癌症免疫疗法的组合物和其用途
|
EP1888751A2
(en)
|
2005-05-25 |
2008-02-20 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
NZ563361A
(en)
|
2005-06-02 |
2011-02-25 |
Schering Corp |
HCV protease inhibitors in combination with food
|
AU2006252553B2
(en)
|
2005-06-02 |
2012-03-29 |
Merck Sharp & Dohme Corp. |
Combination of HCV protease inhibitors with a surfactant
|
EP3211086B1
(en)
|
2005-09-20 |
2021-06-09 |
Menarini Silicon Biosystems S.p.A. |
Methods and composition to generate unique sequence dna probes, labeling of dna probes and the use of these probes
|
US9502624B2
(en)
|
2006-05-18 |
2016-11-22 |
Nichia Corporation |
Resin molding, surface mounted light emitting apparatus and methods for manufacturing the same
|
WO2008020335A2
(en)
|
2006-06-09 |
2008-02-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
WO2009022236A2
(en)
|
2007-08-16 |
2009-02-19 |
Tripep Ab |
Immunogen platform
|
EP2224954B1
(en)
|
2007-11-07 |
2014-01-08 |
Celldex Therapeutics, Inc. |
Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
|
ES2664753T3
(es)
|
2007-12-07 |
2018-04-23 |
Glaxosmithkline Biologicals Sa |
Composiciones de inducción de respuestas inmunes
|
CA2712606A1
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
WO2009130588A2
(en)
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
JP2011523553A
(ja)
|
2008-05-19 |
2011-08-18 |
アデュロ バイオテック |
PrfA*変異株リステリアを含む組成物およびその使用法
|
EA019653B1
(ru)
|
2008-09-26 |
2014-05-30 |
Амбркс Инк. |
Модифицированные полипептиды эритропоэтина животных и их применение
|
US20110286969A1
(en)
|
2008-12-12 |
2011-11-24 |
Schering Corporation |
Deuterated compounds as hepatitis c virus (hcv) inhibitors
|
EP2405943A2
(en)
|
2009-03-09 |
2012-01-18 |
William Henry |
Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
US20110300205A1
(en)
|
2009-07-06 |
2011-12-08 |
Novartis Ag |
Self replicating rna molecules and uses thereof
|
JP2013512246A
(ja)
|
2009-11-25 |
2013-04-11 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
JP2013515068A
(ja)
|
2009-12-22 |
2013-05-02 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス性疾患の治療のための縮合三環式化合物およびその使用方法
|
SG182737A1
(en)
|
2010-01-27 |
2012-08-30 |
Pharma Ltd Ab |
Polyheterocyclic compounds highly potent as hcv inhibitors
|
CA2792121A1
(en)
|
2010-03-09 |
2011-09-15 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
MX339621B
(es)
|
2010-04-13 |
2016-06-02 |
Celldex Therapeutics Inc * |
Anticuerpos que se unen a cd27 humano y uso de los mismos.
|
JP6025721B2
(ja)
|
2010-07-06 |
2016-11-16 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
JP2014515023A
(ja)
|
2011-04-13 |
2014-06-26 |
メルク・シャープ・アンド・ドーム・コーポレーション |
2’−置換ヌクレオシド誘導体およびウイルス疾患の処置のためのその使用方法
|
US8962810B2
(en)
|
2011-06-16 |
2015-02-24 |
AB Pharma Ltd. |
Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof
|
AU2012280901B2
(en)
|
2011-07-06 |
2016-11-10 |
Glaxosmithkline Biologicals S.A. |
Oil-in-water emulsions that contain nucleic acids
|
AU2012280904B2
(en)
|
2011-07-06 |
2017-02-23 |
Glaxosmithkline Biologicals S.A. |
Cationic oil-in-water emulsions
|
US20140378416A1
(en)
|
2011-09-14 |
2014-12-25 |
Michael P. Dwyer |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
EP2768530A1
(en)
|
2011-10-11 |
2014-08-27 |
Novartis AG |
Recombinant self-replicating polycistronic rna molecules
|
US20180044429A1
(en)
|
2015-03-09 |
2018-02-15 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
RU2017133463A
(ru)
|
2015-03-27 |
2019-04-29 |
Орто-Клиникал Дайэгностикс, Инк. |
ПОЛИПЕПТИДЫ NS4a/МОДИФИЦИРОВАННЫЕ NS3 HCV И ИХ ПРИМЕНЕНИЕ
|
EP3313863B1
(en)
*
|
2015-06-29 |
2020-12-23 |
The Board of Trustees of the Leland Stanford Junior University |
Degron fusion constructs and methods for controlling protein production
|
MA44723A
(fr)
|
2016-04-18 |
2019-02-27 |
Celldex Therapeutics Inc |
Anticorps agonistes se liant au cd40 humain et leurs utilisations
|